Kortex Ventures

Kortex Ventures is a global venture capital fund established in 2020 and based in Brazil, focusing primarily on early-stage companies in the health tech and healthcare technology sectors. The firm seeks to collaborate with exceptional entrepreneurs and innovative organizations to advance the future of healthcare through technological solutions. By investing in promising startups, Kortex Ventures aims to drive meaningful change within the healthcare landscape.

Hans Lenk

Managing Director

9 past transactions

Caveo

Seed Round in 2025
Caveo is a digital platform that specializes in financial and accounting solutions for doctors.

Welbe

Series A in 2024
Welbe Care is a healthcare platform that focuses on managing workers' health through data collection and artificial intelligence. Founded in Mexico City in 2021, the company provides an intelligent occupational management system that integrates with the local health ecosystem, including laboratories, clinics, and health service providers. This comprehensive health ecosystem allows businesses to monitor and improve the health and productivity of their employees by identifying potential health issues early on. Additionally, Welbe Care offers a minor medical expenses program with no deductible or copayment, further enhancing accessibility to healthcare services. Through data analysis and population health indicators, the platform enables informed decision-making for employers and promotes overall well-being in the workforce.

Biologix

Venture Round in 2024
Biologix provides a SaaS platform and medical devices that enables health professionals to offer to their patients a simple, low cost and accurate sleep test for obstructive sleep apnea.

SiPhox Health

Series A in 2023
SiPhox Health develops advanced diagnostic solutions for both home use and laboratory settings. The company offers an at-home test kit that evaluates 17 blood biomarkers, focusing on areas such as inflammation, hormonal health, metabolic fitness, and cardiovascular health. Their biosensing platform features a handheld device designed to work with disposable cartridges, integrating biochemistry and photonic chip technology. This innovative approach combines integrated photonics, electronics, and microfluidics to deliver sensitive readings of immunoassays and nucleic acids, facilitating point-of-need testing and enhancing the accessibility of diagnostic tools for users.

Welbe

Seed Round in 2022
Welbe Care is a healthcare platform that focuses on managing workers' health through data collection and artificial intelligence. Founded in Mexico City in 2021, the company provides an intelligent occupational management system that integrates with the local health ecosystem, including laboratories, clinics, and health service providers. This comprehensive health ecosystem allows businesses to monitor and improve the health and productivity of their employees by identifying potential health issues early on. Additionally, Welbe Care offers a minor medical expenses program with no deductible or copayment, further enhancing accessibility to healthcare services. Through data analysis and population health indicators, the platform enables informed decision-making for employers and promotes overall well-being in the workforce.

NeuralMed

Venture Round in 2022
NeuralMed is a healthcare startup that leverages artificial intelligence to enhance medical examinations and decision-making processes. The company specializes in analyzing unstructured data from various sources to create a comprehensive and reliable data matrix. Its proprietary algorithms enable the organization of patient flow by criticality, assisting healthcare professionals in identifying pathologies and structuring reports through the analysis of free text and images. By providing real-time insights, NeuralMed's solutions not only improve diagnostic accuracy but also reduce costs for healthcare institutions. The technology is designed for seamless integration into existing systems, promoting higher user adherence and facilitating better patient care.

ISA Saúde

Series A in 2022
ISA is a digital-first home healthcare provider harnessing technology to bring care directly to patients' home, providing higher quality services at a fraction of the cost. Currently, ISA offers outpatient care, lab work services and immunizations. We are aiming to be the largest non-hospital healthcare company in Latam, by providing access to affordable healthcare services for millions of people through the decentralization of care.

Huna

Pre Seed Round in 2022
We are committed to making early cancer detection faster, cheaper and accessible

Sweetch

Series A in 2021
Sweetch is a behavioral science company that utilizes artificial intelligence and emotional intelligence to provide digital therapeutic solutions aimed at improving clinical outcomes for individuals with chronic conditions. The company's hyper-personalized engagement platform offers tailored recommendations that consider the appropriate timing, tone, and real-world context for each patient's health journey. This approach enables pharmaceutical companies, medical device manufacturers, payers, and healthcare providers to foster continuous relationships and effectively engage with patients at scale, ultimately supporting individuals in achieving their health goals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.